Parameter
| Biomarker | has-miR-150-5p/MALAT1, has-miR335-5p/NEAT1 | Full name | has-microR-150-5p/metastasis associated lung adenocarcinoma transcript 1, has-microR335-5p/NEAT1 | Molecular Type | Nucleic acid |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Prognosis | ||
| Disease | Non-Hodgkin Lymphoma (NHL) | Disease Subtypes | / | ||
| Organ | Lymphoid tissue | Test Sample / Technology Platform | Plasma (RT-qPCR, bioinformatics) | ||
| Pathobiological Mechanisms | High-level combination association with advanced stage and poor prognosis | ||||
| Clinical Availability Status | Validation phase of the study: 113 patients were validated, requiring subtype-specific validation and detection optimization. | ||||
| Notes and Dynamics | Clarify subtype applicability, optimize testing to enhance clinical accessibility. | ||||